Study of Augmented Hyper-CVAD in Acute Lymphoblastic Leukemia Salvage
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if a special combination of chemotherapy
drugs called "augmented hyper-CVAD chemotherapy" given over 6 to 8 months followed by monthly
maintenance chemotherapy for one year can help to control acute lymphoblastic leukemia or
lymphoblastic lymphoma. The safety of this therapy will also be studied.